Porcine interleukin-6 (PIL-6) protein without signal peptide was expressed as a glutathione S-transferase (GST) fusion protein in Escherichia coli. The fusion protein was expressed in an insoluble fraction, however, it was solubilized by refolding procedure using urea. From the solubilized protein, the recombinant PIL-6 (rPIL-6) was purified by a batch method using glutathione sepharose 4B and PreScission TM protease cleavage. By the B3B1 hybridoma cell proliferation assay, biological activity of the purified rPIL-6 was confirmed. Three monoclonal antibodies (MAbs) named 2B-1, 5A-8 and 4C-3 were generated by using the rPIL-6 as an immunogen. Immunoglobulin isotypes of the MAbs were IgG2a (4C-3) and IgG2b (2B-1 and 5A-8). For the epitope analysis, additive enzyme-linked immunosorbent assay and immunoblot analysis using deletion mutants of PIL-6 were performed. These experiments revealed that the two MAbs (2B-1 and 5A-8) recognize an overlapped epitope and the other (4C-3) recognizes a distinct epitope, and all epitopes reside in the region of aa26-64 of PIL-6. KEY WORDS: bacterial expression, interleukin-6, monoclonal antibody, swine.
Interleukin-6 (IL-6) is a multifunctional cytokine with roles in the regulation of the immune responses and host defense reactions. The major biological activities of IL-6 include stimulation of B cells to produce antibodies [3] , induction of acute phase protein synthesis in the liver [1] , stimulation of myeloma, hybridoma and plasmacytoma for proliferation [5, 6, 16] , activation of T cells [15] , and induction of an in vivo pyrogenic response. IL-6 is produced by a variety of cells including monocyte-macrophage, fibroblasts, endothelial cells, T cells, B cells, keratinocytes, mesangial cells, glial cells, chondrocytes, and certain tumor cells [18] .
Disorders of IL-6 level are observed in a number of inflammatory diseases. For example, T cells infiltrate and secrete IL-6 in rheumatoid synovial tissues [2] . IL-6 production is upregulated by a large number of factors including viral infections [17] , bacterial lipopolysaccharide [8] , and cytokines such as IL-1, tumor necrosis factor alpha, interferon gamma, platelet-derived growth factor, IL-3, and granulocyte/macrophage colony-stimulating factor [18] . Furthermore, excessive production of IL-6 was reported to induce a polyclonal B-cell production resulting in hypergammaglobulinemia and autoantibody production [18] . The measurement of IL-6 levels in body fluids as serum or synovial fluid might provide important information for pathophysiological states and diagnosis in patients with certain diseases as viral infection or chronic diseases.
In human and ovine, sensitive capture ELISA using spe-cific MAbs against IL-6 had been developed to measure the IL-6 level in the serum or biological fluids [2, 9] . Although measurements of IL-6 expression in porcine have been performed by using bioassay for the fluid or reverse transcription polymerase chain reaction (RT-PCR) for the immune cells [17] , there exist some problems in its specificity and/or stability. Sensitive and specific ELISA system for IL-6 has not been established because of lack of specific Mabs being convenient and supplied easily. Therefore, useful Mabs are required to develop more reliable detection and determination systems for porcine IL-6 (PIL-6). The purpose of this study is to express recombinant PIL-6 (rPIL-6) in Escherichia coli (E. coli) as immunogen, and to generate and characterize MAbs against the PIL-6 for the studies on its function and cytokine profiles of porcine T cells in the future.
MATERIALS AND METHODS
Preparation of rPIL-6 expressed in E.coli: rPIL-6 was expressed in E. coli as a glutathione S-transferase (GST) fusion protein. The cDNA encoding a mature form of PIL-6 was amplified by PCR from a cDNA library of porcine spleen mononuclear cells using oligonucleotide primers PIL-6 Fw, 5'-CCG GAA CGC CTG GAA GAT G-3' and PIL-6 Rv, 5'-CTA CAT TAT CCG AAT GGC C-3', which were designed on the basis of the sequence data of PIL-6 (DDBJ accession number: M86722). The amplified product was cloned into pT7 Blue-T vector (Novagen, Madison, WI, U.S.A.), and confirmed its authenticity by sequencing analysis. Then, the cDNA was cut-out by digestion with EcoR I and Sal I, and cloned into EcoR I/Sal I sites of a pGEX6P-3 expression vector (Amersham, Piscataway, NJ, U.S.A.) to produce pGEX6P-3/PIL-6. E. coli strain JM109 was trans-formed with pGEX6P-3/PIL-6, and cultured in 2xYTG medium (16 g/l tryptone, 10 g/l yeast extract, 5 g/l NaCl and 20 g/l glucose) supplemented with 100 µg/ml of ampicillin. Then, the expression of the GST-PIL-6 fusion protein was induced by addition of isopropyl-β-D-galactopyranoside. The fusion protein expressed in an insoluble fraction was solubilized by refolding procedure using urea as described previously [7] , and then purified by glutathione sepharose 4B (Amersham) followed by cleavage with PreScission TM protease (Amersham) by a batch method. The purity of the expressed protein was analyzed on 10% SDS-PAGE and its concentration was determined by using a Bio-Rad Protein Assay kit (BIO-RAD, Hercules, CA, U.S.A.).
To express rPIL-6 by a baculovirus expression system, a transfer vector containing PIL-6, was constructed. The fragment encoding an entire open reading frame of PIL-6 cDNA was amplified by PCR using oligonucleotide primers PIL-6 Fws, 5'-GAA ATT CTC TGC AAT GAG AAA GGA-3' and the PIL-6 Rv. The amplified fragment was cloned into pT7 Blue-T, then it was cut out by digestion with BamH I and Xba I and cloned into a pVL1393 vector (BD San Jose, CA, U.S.A.) to produce pVL1393/PIL-6. To obtain recombinant baculoviruses, the pVL1393/PIL-6 was transfected to Spodptera frugiperda (Sf) 9 cells with a linealized AcVAPK6 by the lipofection method as described elsewhere [14] .
Cell proliferation assay: Biological activity of the purified rPIL-6 was examined by the cell proliferation assay using an IL-6-dependent mouse-rat hybridoma, B3B1 cells, as described by Ohashi et al. [10] with some modifications. Briefly, the B3B1 cells were suspended in RPMI1640 medium supplemented with 20% fetal calf serum (FCS), 20 mM HEPES, 1 × 10 -4 M 2-mercaptoethanol and then seeded at 5 × 10 3 cells/well in a 96-well plate. The cells were added with an equal volume of diluted samples or recombinant human IL-6 (Dainipponseiyaku, Osaka, Japan) as a positive control, and cultured for 48 hr at 37°C in a humidified atmosphere of 5% CO 2 . Then, the cell proliferation was measured by using a Cell Counting Kit-8 (WAKO, Osaka, Japan) according to the manufacture's instruction.
Generation of MAbs: Male, 8-weeks-old BALB/c mice were immunized intraperitoneally (i.p.) with 50 µg of rPIL-6 emulsified with 50 % (v/v) Freund's complete adjuvant, and boosted twice at two weeks intervals with an equal mass of rPIL-6 emulsified with Freund's incomplete adjuvant. Three days prior to the fusion procedure, the mice were immunized intravenously (i.v.) with 20 µg of rPIL-6 without adjuvant. Fresh splenocytes were fused with P3U1 mouse myeloma cell line as described elsewhere [11, 19] . Culture supernatants of the hybridomas were screened for antibodies against the rPIL-6 by indirect ELISA, described in the next section and selected hybridomas were cloned twice by the limiting dilution method. Pristane primed male, 8-weeks-old BALB/c mice were then injected i.p. with 1 × 10 7 cloned hybridoma cells per mouse for ascites production. The ascites was collected, centrifuged at 8,500 g for 10 min at 4°C, filtrated, and then purified with Mab Trap ® GII (Amersham) according to the manufacture's instruction. The isotypes of the MAbs were determined using a mouse monoclonal antibody isotyping kit (Amersham).
Characterization of antibodies for PIL-6: The indirect ELISA was used to screen hybridomas for antibodies to rPIL-6. In brief, 96-well microtiter plates (Greiner, Frickenhausen, Germany) were coated with 50 ng/ml of rPIL-6 or GST in a 0.1 M carbonate buffer (5 mM Na 2 CO 3 and 95 mM NaHCO 3 , pH8.7) for 2 hr at room temperature (RT). Following blocking with 100 µl per well of 2% gelatin in phosphate-buffered saline (PBS), 100 µl of hybridoma culture supernatants were added and incubated for 1 hr at RT. The plates were washed 4 times with PBS containing 0.05% Tween-20 (PBS-T), added with peroxidase-conjugated goat anti-mouse IgG antibody, and then incubated for 1 hr at RT. After washing 5 times with PBS-T, 100 µl of the substrate solution (0.04% orthophenylene diamine in 0.05 M citric acid /0.1 M Na 2 HPO 4 buffer containing hydroperoxide, pH 5.0) was added. Then, the reaction was stopped by adding 25 µl of 2.5 M H 2 SO 4 and the absorbance was read by an ELISA plate reader (BIO-RAD) at a test wavelength of 490 nm.
Immunoblot analysis under the reduced condition was performed using the rPIL-6 expressed in E. coli and insect cells as described previously [9] .
Epitope mapping: The hydrophobicity of PIL-6 was examined according to the method of Hopp et al. [4] using a computer program. Hydrophilic regions were targeted for construction of truncated proteins of PIL-6. Namely, cDNAs encoding aa26-128 (Region #1), aa65-128 (Region #2), aa129-213 (Region #3) and aa151-213 (Region #4) were amplified by PCR using following respective combinations of sense and antisense primers: Fw1 (5'-GAA TTC TTC CCT ACC CCG GAA CG-3')-Rv1 (5'-GTC GAC GTA GTC CAG GTA TAT CTG-3'), Fw2 (5'-GAA TTC TCT GCA ATG AGA AAG GA-3')-Rv1, Fw3 (5'-GAA TTC CTC CAG AAA GAG TAT GA-3')-Rv2 (5'-GTC GAC CTA CAT TAT CCG AAT GG-3') and Fw4 (5'-GAA TTC ATC CAG ACC CTG AGG CA-3')-Rv2. The amplified fragments were cloned into pGEX6P-3 vector and recombinant truncated proteins were expressed in E. coli as GST fusion proteins as described above. Then, immunoblot analysis was performed using the GST-fused truncated proteins of PIL-6 as antigens. On the other hand, additive ELISA was performed on culture supernatants from each hybridoma. In brief, 96-well microtiterplates were coated with 4 ng of rPIL-6 and then 50 µl of the culture supernatant from a hybridoma was added alone or in combination with that from another hybridoma following blocking with 1% bovine serum albumin solution. ELISA reactions were done as described in the above section. The additive ELISA index was calculated as follows. We defined OD490 of culture supernatant from hybridoma A as a, OD490 of culture supernatant from hybridoma B as b, and OD490 of combined culture supernatant from hybridoma A and B as c. The additive ELISA index was calculated with the follow-ing formula; ((c-a)+b)/b. This index is set up to approach the value of 2 when the two MAbs recognize different epitopes. On the other hand, if the index approaches the value of 1, these two MAbs are regarded to recognize the same epitope.
RESULTS

Expression of rPIL-6:
The GST-PIL-6 fusion protein was expressed in E. coli. Figure 1 shows the SDS-PAGE analysis of the expressed proteins stained with coomassie brilliant blue. About 47 kDa fusion protein was observed in the insoluble fraction (lane 2), and the protein was successfully solbulized by using urea (lane 3). In lane 5, the purified rPIL-6 after digestion with PreScission TM Protease was observed with a molecular mass of about 21 kDa. Biological activity of the rPIL-6 was evaluated by using an IL-6 dependent mouse-rat hybridoma cell line, B3B1 (Fig. 2) . The purified rPIL-6 exhibited significant biological activity although the maximum absorbance by the protein was lower than that by the positive control.
Production of antibodies to rPIL-6: Before the harvest of splenocytes of mice immunized with the rPIL-6, mouse serum was collected. The serum was examined by the immunoblot analysis using the purified rPIL-6 and GST expressed in E. coli and rPIL-6 protein expressed by a baculovirus system as antigens. The mouse serum reacted with the rPIL-6 expressed in both E. coli and insect cells ( Fig. 3A  and B, lane 1) , but not with the GST protein (data not shown).
Three MAbs were successfully obtained (clone Nos. 2B-1, 5A-8 and 4C-3). The isotypes of the MAbs were found to be IgG2b (2B-1 and 5A-8) and IgG2a (4C-3).
Characterization of MAbs: The purified MAbs and mouse antiserum for PIL-6 were subjected to the immunoblot analysis using rPIL-6 and GST from E. coli and rPIL-6 from insect cells as antigens under the reduced condition (Fig. 3A and B) . MAb 2B-1 reacted with the rPIL-6 from E. coli (Fig. 3A, lane 2) , but not with GST (data not shown). Furthermore, the MAb 2B-1 strongly recognized the rPIL-6 from insect cells (Fig.3B, lane 2) . Whereas, other two MAbs weakly recognized the protein (data not shown). In addition, by the indirect immunofluorescence assay, the purified MAb 2B-1 reacted with the Sf9 cells infected with the recombinant baculovirus (data not shown).
Epitope mapping: The analysis of hydorphobicity plot of PIL-6 revealed that PIL-6 seemed to have five hydrophilic peaks in its molecule (Fig. 4 ). PIL-6 was divided into four fragments (Regions #1:aa26-128, #2:aa65-128, #3:aa129-213 and #4:aa151-213) in Fig. 4 and successfully expressed in E. coli as GST fusion proteins with MWs of about 30, 25, 30 and 25 kDa on SDS-PAGE. In immunoblot analysis using recombinant PIL-6 truncated proteins as antigens, all MAbs recognized the fragment spanning aa26-128 (Region #1) of PIL-6. On the other hand, no MAbs recognized the other regions of PIL-6 and GST. In the additive ELISA, indexes obtained by the MAbs were as follows; 2B-1 and 5A-8 as 1.10, 5A-8 and 4C-3 as 1.83, and 4C-3 and 2B-1 as 1.90. These results showed that the epitopes recognized by the MAbs are present in the region of aa26-64, and the epitope recognized by the 4C-3 is different from that by the other two MAbs.
DISCUSSION
In human and animals, the Mabs against certain cytokines are thought to be strong tools for cytokine analyses in immunological and clinical studies. However, there are sparse information about PIL-6 and also its Mabs. To generate Mabs against PIL6, we first attempted to express the recombinant IL-6 in E. coli as a GST fusion protein. In most cases, the GST fusion proteins expressed in E. coli are not properly folded and precipitate into insoluble aggregates called as "inclusion bodies" in spite of the deletion clones without signal peptides [12] . In this study, the expressed proteins were also insoluble, but successfully solubilized by refolding procedure using urea. In addition, although the difference of posttranscriptional modification from mammalian cells, rPIL-6 purified from E. coli had an efficient biological activity. Furthermore, mice immunized with this rPIL-6 had produced efficient antibodies against PIL-6, suggesting that antigenicity of rPIL-6 had not been lost under the strong denature condition.
Immunoblot analysis was performed using three MAbs obtained in this study. All MAbs reacted with purified rPIL-6 from E. coli under the reduced condition, suggesting that MAbs recognized a linear epitope of the rPIL-6. In addition, MAb 2B-1 had reacted with rPIL-6 from insect cells in the indirect immunofluoerscence assay and native forms of PIL6 from pigs (data not shown), suggesting that this MAb recognizes rPIL-6 from eukaryotic cells in a natural form.
In most cases, regions showing local maxima in a hydrophilicity plot have a high antigenicity because of exposure to the surface of molecules [13] . In fact, PIL-6 has five hydrophilic peaks in its molecule and all Mabs obtained in this study recognized at least two epitopes existed in a first hydrophilic peak (aa26-64). These results suggest the existence of epitopes having strong antigenicity in this region.
In conclusion, we obtained three MAbs against PIL-6 with different epitopes and subtypes. These MAbs generated in this study will be useful for the development of the sensitive capture ELISA to detect PIL-6 for the study of porcine immunology and clinical pathology. 
